Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 470
Immune Disorders Drugs 198
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 128
Drug Discovery 122
Central Nervous System Drugs 107
Endocrine and Metabolic Disorders Drugs 104
Clinical Trials 101
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 91
Leukemia Drugs 84
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 55
Brain Cancer Drugs 51
Skin Cancer Drugs 50
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 35
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 31
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 27
Analgesics 27
Drugs by Therapeutic Area 24
HIV/AIDS Drugs 23
Kidney Cancer Drugs 22
Antibiotics 22
Prostate Cancer Drugs 19
Colon Cancer Drugs 19
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Cough and Cold Drugs 6
Company Reports 5
Anxiety Drugs 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,434 Results (Page 12 of 122)
- Relevance
  Sort by

Antimicrobial Therapeutics - Global Strategic Business Report

 Report
October 2025
494 Pages
Global

From

€5193EUR$5,850USD£4,509GBP

Brain & Spinal Cord Cancer Market - Global Forecast 2025-2032

 Report
October 2025
181 Pages
Global

From

€3147EUR$3,545USD£2,733GBP

€3496EUR$3,939USD£3,036GBP

Glioma Treatment Market - Global Forecast 2025-2032

 Report
October 2025
189 Pages
Global

From

€3147EUR$3,545USD£2,733GBP

€3496EUR$3,939USD£3,036GBP

Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form and Key Geographies

 Report
March 2025
442 Pages
Global

From

€4260EUR$4,799USD£3,699GBP

Cephalosporin Drugs - Global Strategic Business Report

 Report
October 2025
398 Pages
Global

From

€5193EUR$5,850USD£4,509GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2219EUR$2,500USD£1,927GBP

Liver Cancer Drugs - Global Strategic Business Report

 Report
October 2025
277 Pages
Global

From

€5193EUR$5,850USD£4,509GBP

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€3994EUR$4,500USD£3,469GBP

Hepatitis C Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
February 2022
87 Pages
Global

From

€3200EUR$3,862USD£2,876GBP

Hepatocellular Carcinoma Drugs - Global Strategic Business Report

 Report
October 2025
198 Pages
Global

From

€5193EUR$5,850USD£4,509GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

 Report
September 2025
750 Pages
Global

From

€3546EUR$3,995USD£3,079GBP

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025

 Report
September 2025
250 Days
Global

From

€3546EUR$3,995USD£3,079GBP

Brain Tumor Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
November 2022
1018 Pages
Global

From

€2219EUR$2,500USD£1,927GBP

Brain Tumor Drugs Market Analysis & Forecast 2024-2034: Market; By Therapy; By Indication; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2796EUR$3,150USD£2,428GBP

Liver Cancer Drug Market Size, Share & Trends Analysis Report by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Type (Hepatocellular Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Region, and Segment Forecasts 2025-2030

 Report
February 2025
100 Pages
Global

From

€5281EUR$5,950USD£4,586GBP

United States Pre-Exposure Prophylaxis (PrEP) Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
78 Pages
United States

From

€3107EUR$3,500USD£2,698GBP

Febrile Neutropenia - Pipeline Insight, 2025

 Clinical Trials
April 2025
65 Pages
Global

From

€1331EUR$1,500USD£1,156GBP

Schizophrenia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3985EUR$4,490USD£3,461GBP

Immunosuppressants - Global Strategic Business Report

 Report
October 2025
349 Pages
Global

From

€5193EUR$5,850USD£4,509GBP

2,434 Results (Page 12 of 122)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.